Current Postmenopausal Hormone Therapy Use Decreases Risk of ACPA-positive RA
The panel acknowledges research gaps when it comes to taking hormone therapy for chronic illness, particularly as it relates to this younger group of women. The average age of women participating in the Women’s Health Initiative was 64 years, well past the age that menopause usually begins. The task force recommendations “are aimed at older women, who are generally healthy asking, ‘If I take a pill a day, will I prevent a heart attack?’ ” Crandall said. Many doctors have already greatly limited how they apply the treatment, and the risks of hormone therapy are well-known among professional organizations.
For the original version including any supplementary images or video, visit http://www.cnn.com/2012/05/29/health/conditions/hormone-replacement-therapy/index.html
Can hormone therapy help protect the brain?
Noting the literature is somewhat contradictory with respect to the role hormonal/reproductive factors and use of postmenopausal hormone therapy may play in risk of rheumatoid arthritisincluding increased risk, decreased risk, and no associationthe investigators studied the association in women 5070 years of age, stratified by presence/absence of anti-citrullinated protein antibodies (ACPA). After analyzing data from the Swedish population-based Epidemiological Investigation of Rheumatoid Arthritis case-control study, they included 467 incident postmenopausal female cases and 935 randomly selected controls (matched by age and residential area) between 20062011. Of the cases, 239 (62.9%) were ACPA-positive. Participating cases and controls completed an identical questionnaire about postmenopausal hormone therapy use. Current and past users of postmenopausal hormone therapy were compared with never users to obtain odds ratios (ORs) with 95% confidence intervals (CI) by means of unconditional logistic regression models. They observed a decreased risk of developing ACPA-positive rheumatoid arthritis among current users compared with never users of postmenopausal hormone therapy (OR 0.5; 95% CI 0.30.9).
For the original version including any supplementary images or video, visit http://www.empr.com/current-postmenopausal-hormone-therapy-use-decreases-risk-of-acpa-positive-ra/article/318176/
Sex still good. Bone density good. Cognition good. Women have been sold down the river on the life quality benefits of HRT for the majority of women.
For the original version including any supplementary images or video, visit http://thechart.blogs.cnn.com/2012/10/24/can-hormone-therapy-help-protect-the-brain/